跳至主要内容
临床试验/NCT02325921
NCT02325921已完成不适用

Advanced MRI in Renal Tumors.

Radboud University Medical Center1 个研究点 分布在 1 个国家目标入组 39 人开始时间: 2014年10月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
39
试验地点
1
主要终点
Discriminating malignant from benign renal lesions using Apparent Diffusion Coefficient (ADC, a metric obtained by diffusion weighted MRI) value distribution analysis.

研究概览

简要总结

Diagnostic imaging for renal masses of unknown nature using conventional imaging modalities such as 3 phase contrast-enhanced computed tomography (CT) is not always conclusive. After (partial) nephrectomy, 10-20 % of the resected tumors show benign histology which could not be identified on diagnostic imaging. With improved imaging techniques available, leading to improvements in characterisation of renal tumors, the number of unnecessary resections may be reduced. The objective of this study is to assess the ability to discriminate oncocytoma from RCC based on the ADC distribution parameters with addition of, tumor volume, and patient demographic characteristics.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Radiologic diagnosis of renal tumor based on previous ultrasonography, CT or MRI examinations.
  • Signed Institutional Review Board (IRB) approved informed consent form.
  • Being at least 18 years of age.
  • Histopathologically confirmed renal tumor diagnosis.

排除标准

  • Relative contra indications for MRI (metal device/foreign bodies, claustrophobia);
  • Active renal or perirenal infection;
  • Minor and/or incapacitated adult.

结局指标

主要结局

Discriminating malignant from benign renal lesions using Apparent Diffusion Coefficient (ADC, a metric obtained by diffusion weighted MRI) value distribution analysis.

时间窗: 45 months

次要结局

  • Additional value of tumor volume and patient characteristics to discriminate malignant from benign renal lesions.(45 months)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验